[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
News& Events::
Contact us::
Site Facilities::
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 19, Issue 4 (winter 2022) ::
Sci J Iran Blood Transfus Organ 2022, 19(4): 292-300 Back to browse issues page
Establishment of lymphoblastoid cell line producing Anti-RhE antibody using alloimmune thalassemia patient's blood
M. Shekeft , S. Milani , Z. Sharifi , A. Oodi
Abstract:   (419 Views)
Abstract
Background and Objectives
One of the applications of Epstein-Barr virus in research is the immortalization of B lymphocytes and the creation of the lymphoblastoid cell line. People with thalassemia usually need blood transfusion, the main complication of which is alloimmunization. Antibody against RhE antigen causes hemolytic reactions. The aim of this study is to create a lymphoblastoid cell line that produces anti-E using peripheral blood mononuclear cells of alloimmune thalassemia patients against E antigen when exposed to Epstein Bar Virus (EBV).

Materials and Methods
In an experimental study, the mononuclear cells of 3 patients were isolated by Ficol and mixed with EBV. The transformed cells were cultured in RPMI medium containing cyclosporine. After 2-3 weeks, the formation of clones in the wells was checked and the hemagglutination test was performed for the wells containing the growing cells; the total amount of antibody in positive wells was measured by ELISA method.

Results
Exposure of mononuclear cells of patients with EBV led to cell transformation and creation of clones in some wells. The results of hemagglutination and ELISA methods showed that the clones were able to produce antibodies against the RhE antigen.

Conclusions 
Anti-E antibody-producing lymphoblastoid cell line can be created by using sensitized cells of thalassemia patients against RhE antigen and its immortalization by EBV transformation method.
 
Keywords: Key words: Antibodies, Thalassemia, Alloimmunization, EBV
Full-Text [PDF 396 kb]   (291 Downloads) |   |   Full-Text (HTML)  (301 Views)  
Type of Study: Research | Subject: Hematology
Published: 2022/12/31
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shekeft M, Milani S, Sharifi Z, Oodi A. Establishment of lymphoblastoid cell line producing Anti-RhE antibody using alloimmune thalassemia patient's blood. Sci J Iran Blood Transfus Organ 2022; 19 (4) :292-300
URL: http://bloodjournal.ir/article-1-1454-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 4 (winter 2022) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4645